ERS clinical practice guidelines on treatment of sarcoidosis
RP Baughman, D Valeyre, P Korsten… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
[PDF][PDF] Early View
RP Baughman, D Valeyre, P Korsten, AG Mathioudakis… - 2021 - researchgate.net
Background: The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
ERS clinical practice guidelines on treatment of sarcoidosis
RP Baughman, D Valeyre… - The European …, 2021 - scholarlycommons.henryford.com
BACKGROUND: The major reasons to treat sarcoidosis are to lower the morbidity and
mortality risk or to improve quality of life (QoL). The indication for treatment varies depending …
mortality risk or to improve quality of life (QoL). The indication for treatment varies depending …
ERS clinical practice guidelines on treatment of sarcoidosis.
RP Baughman, D Valeyre, P Korsten… - The European …, 2021 - europepmc.org
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
ERS clinical practice guidelines on treatment of sarcoidosis
RP Baughman, D Valeyre, P Korsten… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
ERS clinical practice guidelines on treatment of sarcoidosis
RP Baughman, D Valeyre… - European …, 2021 - cris.maastrichtuniversity.nl
BACKGROUND: The major reasons to treat sarcoidosis are to lower the morbidity and
mortality risk or to improve quality of life (QoL). The indication for treatment varies depending …
mortality risk or to improve quality of life (QoL). The indication for treatment varies depending …
[PDF][PDF] ERS clinical practice guidelines on treatment of sarcoidosis
RP Baughman, D Valeyre, P Korsten - legeforeningen.no
ERS clinical practice guidelines on treatment of sarcoidosis Page 1 1 Vurdering av ERS clinical
practice guidelines on treatment of sarcoidosis Baughman RP, Valeyre D, Korsten P, et al. Eur …
practice guidelines on treatment of sarcoidosis Baughman RP, Valeyre D, Korsten P, et al. Eur …
[PDF][PDF] Early View
RP Baughman, D Valeyre, P Korsten, AG Mathioudakis… - 2021 - qdcxjkg.com
Background: The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
[PDF][PDF] Early View
RP Baughman, D Valeyre, P Korsten, AG Mathioudakis… - 2021 - files.medelement.com
Background: The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
risk or to improve quality of life (QoL). The indication for treatment varies depending on …
ERS clinical practice guidelines on treatment of sarcoidosis
RP Baughman, D Valeyre, P Korsten… - European Respiratory …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> The major reasons to treat
sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL) …
sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL) …